It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Global stakeholders including the World Health Organization rely on predictive models for developing strategies and setting targets for tuberculosis care and control programs. Failure to account for variation in individual risk leads to substantial biases that impair data interpretation and policy decisions. Anticipated impediments to estimating heterogeneity for each parameter are discouraging despite considerable technical progress in recent years. Here we identify acquisition of infection as the single process where heterogeneity most fundamentally impacts model outputs, due to selection imposed by dynamic forces of infection. We introduce concrete metrics of risk inequality, demonstrate their utility in mathematical models, and pack the information into a risk inequality coefficient (RIC) which can be calculated and reported by national tuberculosis programs for use in policy development and modeling.
Failure to account for heterogeneity in TB risk can mislead model-based evaluation of proposed interventions. Here, the authors introduce a metric to estimate the distribution of risk in populations from routinely collected data and find that variation in infection acquisition is the most impactful.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Liverpool School of Tropical Medicine, Liverpool, United Kingdom (GRID:grid.48004.38) (ISNI:0000 0004 1936 9764); Universidade do Porto, CIBIO-InBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, Vairão, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226)
2 Universidade do Porto, CIBIO-InBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, Vairão, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226)
3 Universidade Federal do Espírito Santo, Departamento de Estatística, Vitória, Brazil (GRID:grid.412371.2) (ISNI:0000 0001 2167 4168)
4 Liverpool School of Tropical Medicine, Liverpool, United Kingdom (GRID:grid.48004.38) (ISNI:0000 0004 1936 9764)
5 National Lung Hospital, Hanoi, Vietnam (GRID:grid.48004.38)
6 Universidade Federal do Espírito Santo, Laboratório de Epidemiologia, Vitória, Brazil (GRID:grid.412371.2) (ISNI:0000 0001 2167 4168)
7 Universidade do Porto, Faculdade de Medicina, and EPIUnit, Instituto de Saúde Pública, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226)
8 National Lung Hospital, Hanoi, Vietnam (GRID:grid.5808.5)
9 University of California San Francisco, Division of Pulmonary and Critical Care Medicine, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
10 Global TB Programme, World Health Organization, 1211 Geneva 27, Geneva, Switzerland (GRID:grid.3575.4) (ISNI:0000000121633745); Unité Mixte Internationale TransVIHMI (UMI 233 IRD – U1175 INSERM – Université de Montpellier), Institut de Recherche pour le Développement (IRD), Montpellier, France (GRID:grid.4399.7) (ISNI:0000000122879528)